ASP Isotopes (ASPI) Financials

$5.83 +0.43 (+7.96%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$5.81 -0.02 (-0.34%)

As of 05/2/2025 07:30 PM Eastern

Annual Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-4.95	-16	-35
Consolidated Net Income / (Loss)	-4.95	-16	-32
Net Income / (Loss) Continuing Operations	-4.95	-16	-32
Total Pre-Tax Income	-4.95	-16	-32
Total Operating Income	-5.10	-16	-26
Total Gross Profit	0.00	0.14	1.60
Total Revenue	0.00	0.43	4.14
Operating Revenue	0.00	0.43	4.14
Total Cost of Revenue	0.00	0.29	2.54
Operating Cost of Revenue	0.00	0.29	2.54
Total Operating Expenses	5.10	16	28
Selling, General & Admin Expense	3.83	15	25
Research & Development Expense	1.27	0.76	3.14
Total Other Income / (Expense), net	0.15	-0.26	-5.96
Interest Expense	0.00	0.12	0.26
Interest & Investment Income	0.00	0.01	1.24
Other Income / (Expense), net	0.15	-0.15	-6.94
Income Tax Expense	0.00	-0.01	0.11
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-0.01	-0.09
Basic Earnings per Share	-	($0.49)	($0.63)
Weighted Average Basic Shares Outstanding	26.79M	33.07M	55.67M
Diluted Earnings per Share	-	($0.49)	($0.63)
Weighted Average Diluted Shares Outstanding	26.79M	33.07M	55.67M
Weighted Average Basic & Diluted Shares Outstanding	26.79M	33.07M	72.07M

This table shows ASP Isotopes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-1.81	-	-3.62	-4.29	-4.22	-4.16	-6.95	-12	-7.27	-9.18
Consolidated Net Income / (Loss)	-3.91	-	-3.62	-4.29	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22
Net Income / (Loss) Continuing Operations	-3.91	-	-3.62	-4.29	-4.22	-4.17	-7.06	-8.88	-7.36	-9.13
Total Pre-Tax Income	-3.91	-	-3.62	-4.29	-4.22	-4.18	-7.01	-8.87	-7.36	-9.07
Total Operating Income	-1.95	-	-3.72	-4.35	-3.95	-4.02	-5.81	-7.46	-5.43	-7.65
Total Gross Profit	0.00	-	0.00	0.00	0.00	0.14	0.28	0.42	0.29	0.61
Total Revenue	0.00	-	0.00	0.00	0.00	0.43	0.84	1.02	1.09	1.19
Operating Revenue	-	-	0.00	0.00	0.00	0.43	0.84	1.02	1.09	1.19
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	0.29	0.56	0.60	0.79	0.59
Operating Cost of Revenue	-	-	0.00	0.00	0.00	0.29	0.56	0.60	0.79	0.59
Total Operating Expenses	3.91	-	3.72	4.35	3.95	4.16	6.09	7.88	5.73	8.25
Selling, General & Admin Expense	1.21	-	3.52	4.09	3.71	4.10	5.88	7.41	4.69	6.84
Research & Development Expense	0.75	-	0.21	0.25	0.24	0.07	0.22	0.47	1.03	1.42
Total Other Income / (Expense), net	-0.00	-	0.11	0.06	-0.28	-0.15	-1.20	-1.41	-1.93	-1.42
Interest Expense	-	-	0.00	0.00	0.00	0.12	0.01	0.07	0.09	0.09
Interest & Investment Income	0.00	-	0.00	0.00	0.00	0.00	0.01	0.04	0.60	0.58
Other Income / (Expense), net	-0.00	-	0.11	0.06	-0.28	-0.04	-1.20	-1.38	-2.44	-1.92
Income Tax Expense	-	-	0.00	0.00	0.00	-0.01	0.05	0.01	-0.01	0.06
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	0.00	-0.01	-0.02	0.05	-0.08	-0.04
Weighted Average Basic Shares Outstanding	30.11M	26.79M	29.14M	29.80M	31.15M	33.07M	51.76M	66.69M	61.53M	55.67M
Weighted Average Diluted Shares Outstanding	-	26.79M	29.14M	29.80M	31.15M	33.07M	51.76M	66.69M	61.53M	55.67M
Weighted Average Basic & Diluted Shares Outstanding	-	26.79M	29.14M	29.80M	31.15M	33.07M	44.56M	49.14M	71.39M	72.07M

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-0.77	5.52	54
Net Cash From Operating Activities	-2.94	-5.41	-17
Net Cash From Continuing Operating Activities	-2.94	-5.41	-17
Net Income / (Loss) Continuing Operations	-4.95	-16	-32
Consolidated Net Income / (Loss)	-4.95	-16	-32
Depreciation Expense	0.00	0.04	0.47
Non-Cash Adjustments To Reconcile Net Income	1.93	9.58	18
Changes in Operating Assets and Liabilities, net	0.07	1.26	-2.34
Net Cash From Investing Activities	-4.47	-2.45	-11
Net Cash From Continuing Investing Activities	-4.47	-2.45	-11
Purchase of Property, Plant & Equipment	-4.47	-2.33	-9.68
Acquisitions	0.00	-0.12	0.00
Other Investing Activities, net	-	0.00	-1.70
Net Cash From Financing Activities	6.64	13	83
Net Cash From Continuing Financing Activities	6.64	13	83
Repayment of Debt	0.00	-0.70	-0.61
Repurchase of Common Equity	-1.47	-0.56	-3.65
Issuance of Debt	0.00	0.53	26
Issuance of Common Equity	8.12	14	53
Other Financing Activities, net	-0.01	-0.01	7.27

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-	0.82	2.13	-1.71	-0.47	5.57	14	6.53	23	11
Net Cash From Operating Activities	-	-0.86	-1.44	-1.26	-0.65	-2.06	-2.97	-5.12	-4.84	-3.76
Net Cash From Continuing Operating Activities	-	-1.80	-2.01	-1.51	0.17	-2.06	-5.03	-0.60	-7.30	-3.76
Net Income / (Loss) Continuing Operations	-	-1.30	-3.62	-4.29	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22
Consolidated Net Income / (Loss)	-	-1.30	-3.62	-4.29	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22
Depreciation Expense	-	-	0.00	0.00	0.00	0.04	0.10	0.15	0.18	0.05
Non-Cash Adjustments To Reconcile Net Income	-	0.99	2.14	2.37	2.90	2.16	1.15	5.88	5.91	4.65
Changes in Operating Assets and Liabilities, net	-	-1.43	-0.55	0.38	1.52	-0.09	0.58	2.36	-6.04	0.76
Net Cash From Investing Activities	-	-0.90	-0.36	-0.15	-0.68	-1.26	-1.25	-2.62	-4.48	-3.02
Net Cash From Continuing Investing Activities	-	-0.90	-0.36	-0.15	-0.68	-1.26	-1.25	-2.62	-4.48	-3.02
Purchase of Property, Plant & Equipment	-	-0.90	-0.36	-0.15	-0.68	-1.14	-1.25	-2.62	-4.48	-1.32
Net Cash From Financing Activities	-	3.79	4.49	-	-	8.89	20	12	32	18
Net Cash From Continuing Financing Activities	-	3.79	4.49	-	-	8.89	20	12	32	18
Repayment of Debt	-	0.01	0.00	-	-	-0.70	-0.26	-0.18	-	-0.17
Repurchase of Common Equity	-	-1.21	-	-	-	-0.06	-	-	-2.19	-1.45
Issuance of Debt	-	-	0.00	-	-	0.53	21	5.39	-	0.50
Issuance of Common Equity	-	5.00	5.00	-	-	9.13	0.00	5.54	29	19
Other Financing Activities, net	-	-	-0.51	0.51	-	-0.01	-0.01	1.48	5.57	0.23

This table presents ASP Isotopes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	12	28	94
Total Current Assets	3.30	11	66
Cash & Equivalents	2.39	7.91	62
Accounts Receivable	0.00	0.22	0.71
Inventories, net	-	0.00	0.07
Prepaid Expenses	0.91	1.66	3.05
Other Current Assets	0.00	0.72	0.03
Plant, Property, & Equipment, net	8.20	11	22
Total Noncurrent Assets	0.99	6.32	6.25
Goodwill	0.00	3.27	3.17
Noncurrent Deferred & Refundable Income Taxes	-	0.00	0.03
Other Noncurrent Operating Assets	0.99	3.05	3.05
Total Liabilities & Shareholders' Equity	12	28	94
Total Liabilities	2.68	8.71	43
Total Current Liabilities	1.94	5.67	7.06
Short-Term Debt	0.03	0.47	0.94
Accounts Payable	1.35	1.11	1.02
Accrued Expenses	0.36	1.31	2.28
Current Deferred Revenue	0.00	0.88	0.88
Other Current Liabilities	0.19	1.90	1.94
Total Noncurrent Liabilities	0.74	3.04	36
Long-Term Debt	-	0.00	33
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.11	0.00
Other Noncurrent Operating Liabilities	0.74	2.93	2.69
Commitments & Contingencies	-	0.00	0.00
Total Equity & Noncontrolling Interests	9.82	19	51
Total Preferred & Common Equity	9.82	16	48
Preferred Stock	0.00	0.00	0.00
Total Common Equity	9.82	16	48
Common Stock	17	41	106
Retained Earnings	-7.55	-24	-56
Accumulated Other Comprehensive Income / (Loss)	0.26	-0.92	-2.16
Noncontrolling Interest	0.00	2.53	3.27

This table presents ASP Isotopes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	12	45	55	84
Total Current Assets	2.73	26	32	56
Cash & Equivalents	2.29	24	28	52
Accounts Receivable	-	0.35	0.52	0.56
Inventories, net	-	-	-	0.08
Prepaid Expenses	0.44	1.93	3.25	3.87
Other Current Assets	-	0.00	0.05	0.00
Plant, Property, & Equipment, net	8.35	14	18	23
Total Noncurrent Assets	0.80	4.85	4.91	5.05
Goodwill	-	3.17	3.29	3.46
Other Noncurrent Operating Assets	0.80	1.68	1.63	1.59
Total Liabilities & Shareholders' Equity	12	45	55	84
Total Liabilities	3.23	32	40	42
Total Current Liabilities	2.60	7.33	8.01	7.43
Short-Term Debt	0.03	0.21	0.03	0.03
Accounts Payable	0.40	2.22	2.43	1.80
Accrued Expenses	1.09	1.77	2.46	1.76
Current Deferred Revenue	0.88	0.88	0.88	0.88
Other Current Liabilities	0.19	2.25	2.21	2.95
Total Noncurrent Liabilities	0.63	25	32	35
Long-Term Debt	-	22	29	32
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.06	0.07	0.08
Other Noncurrent Operating Liabilities	0.63	2.95	3.23	2.83
Commitments & Contingencies	-	-	-	0.00
Total Equity & Noncontrolling Interests	8.64	13	14	42
Total Preferred & Common Equity	8.64	11	11	39
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	8.64	11	11	39
Common Stock	30	43	51	85
Retained Earnings	-20	-31	-40	-47
Accumulated Other Comprehensive Income / (Loss)	-1.29	-1.46	-0.70	0.60
Noncontrolling Interest	-	2.51	3.35	3.32

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	0.00%	0.00%	857.04%
EBITDA Growth	0.00%	-226.43%	-103.18%
EBIT Growth	0.00%	-227.18%	-105.62%
NOPAT Growth	0.00%	-214.61%	-64.28%
Net Income Growth	0.00%	-229.50%	-98.98%
EPS Growth	0.00%	0.00%	-28.57%
Operating Cash Flow Growth	0.00%	-84.10%	-208.47%
Free Cash Flow Firm Growth	0.00%	0.00%	-102.53%
Invested Capital Growth	0.00%	52.67%	107.57%
Revenue Q/Q Growth	0.00%	0.00%	22.49%
EBITDA Q/Q Growth	0.00%	-1,667,112.69%	-20.10%
EBIT Q/Q Growth	0.00%	0.00%	-19.80%
NOPAT Q/Q Growth	0.00%	0.00%	-15.95%
Net Income Q/Q Growth	0.00%	0.00%	-18.45%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	-28.34%	-11.36%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	3.38%
Invested Capital Q/Q Growth	0.00%	78.39%	6.28%
Profitability Metrics	-	-	-
Gross Margin	0.00%	32.09%	38.60%
EBITDA Margin	0.00%	-3,730.34%	-791.94%
Operating Margin	0.00%	-3,704.63%	-635.91%
EBIT Margin	0.00%	-3,738.99%	-803.31%
Profit (Net Income) Margin	0.00%	-3,762.85%	-782.36%
Tax Burden Percent	100.00%	99.96%	100.34%
Interest Burden Percent	99.93%	100.68%	97.06%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-119.11%	-105.29%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-15.68%	-25.33%
Return on Net Nonoperating Assets (RNNOA)	0.00%	5.36%	12.65%
Return on Equity (ROE)	-100.74%	-113.75%	-92.64%
Cash Return on Invested Capital (CROIC)	0.00%	-160.81%	-175.24%
Operating Return on Assets (OROA)	0.00%	-80.88%	-54.62%
Return on Assets (ROA)	0.00%	-81.39%	-53.20%
Return on Common Equity (ROCE)	-100.74%	-103.69%	-84.96%
Return on Equity Simple (ROE_SIMPLE)	-50.37%	-99.99%	-67.69%
Net Operating Profit after Tax (NOPAT)	-3.57	-11	-18
NOPAT Margin	0.00%	-2,593.24%	-445.14%
Net Nonoperating Expense Percent (NNEP)	-58.41%	-103.43%	-79.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-58.18%	-21.57%
Cost of Revenue to Revenue	0.00%	67.91%	61.40%
SG&A Expenses to Revenue	0.00%	3,560.15%	598.77%
R&D to Revenue	0.00%	176.57%	75.74%
Operating Expenses to Revenue	0.00%	3,736.72%	674.51%
Earnings before Interest and Taxes (EBIT)	-4.95	-16	-33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.95	-16	-33
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	5.36	6.75
Price to Tangible Book Value (P/TBV)	0.00	6.70	7.23
Price to Revenue (P/Rev)	0.00	201.61	78.04
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	7.23	12.65
Enterprise Value to Revenue (EV/Rev)	0.00	190.29	72.18
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.03	0.67
Long-Term Debt to Equity	0.00	0.00	0.65
Financial Leverage	-0.24	-0.34	-0.50
Leverage Ratio	1.27	1.40	1.74
Compound Leverage Factor	1.27	1.41	1.69
Debt to Total Capital	0.34%	2.44%	40.18%
Short-Term Debt to Total Capital	0.34%	2.44%	1.10%
Long-Term Debt to Total Capital	0.00%	0.00%	39.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	13.13%	3.82%
Common Equity to Total Capital	99.66%	84.43%	56.00%
Debt to EBITDA	-0.01	-0.03	-1.05
Net Debt to EBITDA	0.48	0.46	0.84
Long-Term Debt to EBITDA	0.00	0.00	-1.02
Debt to NOPAT	-0.01	-0.04	-1.86
Net Debt to NOPAT	0.66	0.66	1.49
Long-Term Debt to NOPAT	0.00	0.00	-1.81
Altman Z-Score	0.00	3.09	3.29
Noncontrolling Interest Sharing Ratio	0.00%	8.85%	8.29%
Liquidity Ratios	-	-	-
Current Ratio	1.71	1.85	9.31
Quick Ratio	1.23	1.43	8.87
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-15	-31
Operating Cash Flow to CapEx	-65.72%	-232.16%	-172.56%
Free Cash Flow to Firm to Interest Expense	0.00	-127.88	-118.61
Operating Cash Flow to Interest Expense	0.00	-45.66	-64.49
Operating Cash Flow Less CapEx to Interest Expense	0.00	-65.32	-101.87
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.02	0.07
Accounts Receivable Turnover	0.00	0.00	8.98
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.05	0.25
Accounts Payable Turnover	0.00	0.24	2.39
Days Sales Outstanding (DSO)	0.00	0.00	40.67
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	1,530.92	152.99
Cash Conversion Cycle (CCC)	0.00	-1,530.92	-112.33
Capital & Investment Metrics	-	-	-
Invested Capital	7.46	11	24
Invested Capital Turnover	0.00	0.05	0.24
Increase / (Decrease) in Invested Capital	0.00	3.93	12
Enterprise Value (EV)	0.00	82	299
Market Capitalization	0.00	87	323
Book Value per Share	$0.37	$0.33	$0.67
Tangible Book Value per Share	$0.37	$0.27	$0.63
Total Capital	9.85	19	86
Total Debt	0.03	0.47	34
Total Long-Term Debt	0.00	0.00	33
Net Debt	-2.36	-7.44	-28
Capital Expenditures (CapEx)	4.47	2.33	9.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.99	-2.60	-2.27
Debt-free Net Working Capital (DFNWC)	1.40	5.31	60
Net Working Capital (NWC)	1.37	4.84	59
Net Nonoperating Expense (NNE)	1.38	5.06	14
Net Nonoperating Obligations (NNO)	-2.36	-7.44	-28
Total Depreciation and Amortization (D&A)	0.00	0.04	0.47
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-600.77%	-54.67%
Debt-free Net Working Capital to Revenue	0.00%	1,225.49%	1,438.74%
Net Working Capital to Revenue	0.00%	1,116.86%	1,416.08%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.63)
Adjusted Weighted Average Basic Shares Outstanding	0.00	33.07M	55.67M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.63)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	33.07M	55.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	33.07M	72.07M
Normalized Net Operating Profit after Tax (NOPAT)	-3.57	-11	-18
Normalized NOPAT Margin	0.00%	-2,593.24%	-445.14%
Pre Tax Income Margin	0.00%	-3,764.27%	-779.67%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	-136.58	-128.60
NOPAT to Interest Expense	0.00	-94.73	-71.26
EBIT Less CapEx to Interest Expense	0.00	-156.24	-165.98
NOPAT Less CapEx to Interest Expense	0.00	-114.39	-108.64
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-29.63%	-3.46%	-11.25%

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	175.71%
EBITDA Growth	0.00%	0.00%	0.00%	0.00%	-115.98%	0.00%	-89.22%	-103.56%	-82.22%	-136.43%
EBIT Growth	0.00%	0.00%	0.00%	0.00%	-116.02%	0.00%	-93.91%	-106.23%	-86.35%	-135.43%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	-101.99%	0.00%	-56.11%	-71.53%	-37.68%	-90.10%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	-7.92%	0.00%	-92.66%	-107.20%	-74.20%	-121.12%
EPS Growth	0.00%	0.00%	0.00%	0.00%	-133.33%	0.00%	0.00%	0.00%	14.29%	0.00%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-138.65%	-105.57%	-307.72%	-640.92%	-82.76%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-114.98%	-161.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	52.67%	0.00%	0.00%	248.42%	107.57%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	94.07%	21.65%	6.40%	9.76%
EBITDA Q/Q Growth	0.00%	100.00%	0.00%	-18.71%	1.09%	4.73%	-69.15%	-27.71%	11.46%	-23.62%
EBIT Q/Q Growth	0.00%	100.00%	0.00%	-18.59%	1.43%	3.88%	-72.60%	-26.12%	10.94%	-21.44%
NOPAT Q/Q Growth	0.00%	100.00%	0.00%	-16.72%	9.22%	-1.94%	-44.53%	-28.25%	27.14%	-40.75%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-18.57%	1.49%	1.24%	-13,426.27%	-27.52%	17.18%	-25.36%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-67.62%	13.01%	48.03%	-214.91%	-44.39%	-72.52%	5.55%	22.32%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	26.26%	-128.71%	-32.45%	3.76%	10.47%
Invested Capital Q/Q Growth	0.00%	0.00%	-100.00%	0.00%	0.00%	78.39%	-0.29%	33.96%	46.23%	6.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	32.09%	33.18%	41.18%	27.03%	50.74%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-929.61%	-810.25%	-850.59%	-707.83%	-797.18%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-929.07%	-691.95%	-729.48%	-499.55%	-640.58%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-938.03%	-834.28%	-864.93%	-724.01%	-801.01%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-963.04%	-828.80%	-868.77%	-676.24%	-772.36%
Tax Burden Percent	100.07%	0.00%	100.00%	100.00%	100.00%	99.85%	99.32%	100.16%	99.89%	101.69%
Interest Burden Percent	199.85%	0.00%	99.99%	99.97%	99.92%	102.82%	100.02%	100.29%	93.51%	94.82%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	-29.87%	-108.59%	-154.06%	-82.62%	-106.06%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	-2.22%	238.73%	-1,009.54%	-50.35%	-83.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.76%	-30.54%	-60.17%	21.88%	41.92%
Return on Equity (ROE)	0.00%	-100.74%	0.00%	0.00%	0.00%	-29.11%	-139.13%	-214.23%	-60.74%	-64.15%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	-160.81%	-423.45%	-395.42%	-221.91%	-175.24%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	-20.29%	-46.81%	-72.52%	-51.03%	-54.47%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	-20.83%	-46.51%	-72.84%	-47.67%	-52.52%
Return on Common Equity (ROCE)	0.00%	-100.74%	0.00%	0.00%	0.00%	-26.54%	-112.33%	-164.26%	-56.76%	-58.83%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-186.77%	-220.12%	-70.74%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.37	0.00	-2.61	-3.04	-2.76	-2.82	-4.07	-5.22	-3.80	-5.35
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-650.35%	-484.36%	-510.64%	-349.69%	-448.41%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	0.00%	-129.60%	-27.65%	-347.31%	855.48%	-32.27%	-22.13%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-14.59%	-	-	-	-6.26%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	67.91%	66.82%	58.82%	72.97%	49.26%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	946.11%	699.53%	724.37%	431.48%	572.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	15.05%	25.60%	46.30%	95.10%	118.61%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	961.16%	725.13%	770.66%	526.58%	691.32%
Earnings before Interest and Taxes (EBIT)	-1.96	0.00	-3.62	-4.29	-4.23	-4.06	-7.01	-8.84	-7.87	-9.56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.96	0.00	-3.60	-4.27	-4.23	-4.03	-6.81	-8.70	-7.70	-9.52
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	5.36	19.15	14.38	4.79	6.75
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	6.70	27.40	20.51	5.26	7.23
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	201.61	158.19	69.00	54.79	78.04
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	7.23	17.81	10.69	7.59	12.65
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	190.29	158.85	70.83	49.93	72.18
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.03	1.71	2.03	0.76	0.67
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	1.69	2.03	0.76	0.65
Financial Leverage	0.00	-0.24	0.00	0.00	-0.26	-0.34	-0.13	0.06	-0.43	-0.50
Leverage Ratio	0.00	1.27	0.00	0.00	1.37	1.40	3.48	3.81	1.90	1.74
Compound Leverage Factor	0.00	0.00	0.00	0.00	1.37	1.44	3.48	3.82	1.77	1.65
Debt to Total Capital	0.00%	0.34%	0.00%	0.00%	0.39%	2.44%	63.05%	66.97%	43.09%	40.18%
Short-Term Debt to Total Capital	0.00%	0.34%	0.00%	0.00%	0.39%	2.44%	0.59%	0.07%	0.05%	1.10%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	62.46%	66.90%	43.05%	39.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	13.13%	7.12%	7.71%	4.49%	3.82%
Common Equity to Total Capital	0.00%	99.66%	0.00%	0.00%	99.61%	84.43%	29.84%	25.33%	52.42%	56.00%
Debt to EBITDA	0.00	-0.01	0.00	0.00	34.94	-0.03	-1.14	-1.22	-1.16	-1.05
Net Debt to EBITDA	0.00	0.48	0.00	0.00	-2,325.03	0.46	0.09	-0.04	0.72	0.84
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-1.13	-1.22	-1.16	-1.02
Debt to NOPAT	0.00	-0.01	0.00	0.00	0.00	-0.04	-1.75	-1.96	-2.00	-1.86
Net Debt to NOPAT	0.00	0.66	0.00	0.00	0.00	0.66	0.13	-0.06	1.24	1.49
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-1.73	-1.96	-2.00	-1.81
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	4.54	2.80	1.37	2.28	4.12
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	8.85%	19.26%	23.33%	6.55%	8.29%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.71	0.00	0.00	1.05	1.85	3.57	4.00	7.55	9.31
Quick Ratio	0.00	1.23	0.00	0.00	0.88	1.43	3.31	3.59	7.02	8.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	0.00	-9.15	-6.75	-15	-20	-20	-18
Operating Cash Flow to CapEx	0.00%	-95.51%	-399.10%	-857.67%	-95.85%	-180.27%	-238.43%	-195.45%	-107.93%	-284.25%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	-56.91	-1,119.13	-295.87	-216.23	-207.08
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	-17.35	-215.44	-74.19	-53.21	-44.21
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-26.98	-305.79	-112.15	-102.51	-59.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.02	0.06	0.08	0.07	0.07
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.98
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.22	0.25
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.24	0.00	0.00	2.05	2.39
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	40.67
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	1,530.92	0.00	0.00	178.36	152.99
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	-1,530.92	0.00	0.00	-178.36	-112.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	7.46	0.00	0.00	6.39	11	11	15	22	24
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.05	0.22	0.30	0.24	0.24
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	0.00	6.39	3.93	11	15	16	12
Enterprise Value (EV)	5.00	0.00	0.00	0.00	0.00	82	202	163	169	299
Market Capitalization	5.00	0.00	0.00	0.00	0.00	87	201	158	185	323
Book Value per Share	$0.00	$0.37	$0.00	$0.00	$0.28	$0.33	$0.22	$0.21	$0.58	$0.67
Tangible Book Value per Share	$0.00	$0.37	$0.00	$0.00	$0.28	$0.27	$0.15	$0.15	$0.53	$0.63
Total Capital	0.00	9.85	0.00	0.00	8.67	19	35	43	74	86
Total Debt	0.00	0.03	0.00	0.00	0.03	0.47	22	29	32	34
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	22	29	32	33
Net Debt	0.00	-2.36	0.00	0.00	-2.25	-7.44	-1.67	0.86	-20	-28
Capital Expenditures (CapEx)	0.00	0.90	0.36	0.15	0.68	1.14	1.25	2.62	4.48	1.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-0.99	0.00	0.00	-2.13	-2.60	-4.84	-4.17	-2.87	-2.27
Debt-free Net Working Capital (DFNWC)	0.00	1.40	0.00	0.00	0.16	5.31	19	24	49	60
Net Working Capital (NWC)	0.00	1.37	0.00	0.00	0.13	4.84	19	24	49	59
Net Nonoperating Expense (NNE)	2.54	0.00	1.01	1.24	1.46	1.35	2.89	3.66	3.55	3.87
Net Nonoperating Obligations (NNO)	0.00	-2.36	0.00	0.00	-2.25	-7.44	-1.67	0.86	-20	-28
Total Depreciation and Amortization (D&A)	0.00	0.00	0.02	0.02	0.00	0.04	0.20	0.15	0.18	0.05
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	-600.77%	-380.09%	-181.67%	-84.97%	-54.67%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	1,225.49%	1,496.08%	1,049.44%	1,439.29%	1,438.74%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	1,116.86%	1,479.86%	1,048.06%	1,438.31%	1,416.08%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	($0.12)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	26.79M	0.00	0.00	48.77M	33.07M	51.76M	66.69M	61.53M	55.67M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	($0.12)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	26.79M	0.00	0.00	48.77M	33.07M	51.76M	66.69M	61.53M	55.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.14)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	26.79M	0.00	0.00	31.15M	33.07M	44.56M	49.14M	71.39M	72.07M
Normalized Net Operating Profit after Tax (NOPAT)	-1.37	0.00	-2.61	-3.04	-2.76	-2.82	-4.07	-5.22	-3.80	-5.35
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-650.35%	-484.36%	-510.64%	-349.69%	-448.41%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-964.46%	-834.47%	-867.42%	-677.01%	-759.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-34.26	-508.48	-128.00	-86.57	-112.46
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-23.76	-295.21	-75.57	-41.81	-62.96
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-43.89	-598.83	-165.96	-135.87	-128.02
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-33.38	-385.57	-113.53	-91.11	-78.51
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-29.63%	0.00%	0.00%	0.00%	-3.46%	0.00%	-0.24%	-8.22%	-11.25%

Frequently Asked Questions About ASP Isotopes' Financials

When does ASP Isotopes's fiscal year end?

According to the most recent income statement we have on file, ASP Isotopes' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ASP Isotopes' net income changed over the last 2 years?

ASP Isotopes' net income appears to be on an upward trend, with a most recent value of -$32.42 million in 2024, rising from -$4.95 million in 2022. The previous period was -$16.29 million in 2023. View ASP Isotopes' forecast to see where analysts expect ASP Isotopes to go next.

What is ASP Isotopes's operating income?

ASP Isotopes's total operating income in 2024 was -$26.35 million, based on the following breakdown:

Total Gross Profit: $1.60 million
Total Operating Expenses: $27.95 million

How has ASP Isotopes revenue changed over the last 2 years?

Over the last 2 years, ASP Isotopes' total revenue changed from $0.00 in 2022 to $4.14 million in 2024, a change of 414,422,600.0%.

How much debt does ASP Isotopes have?

ASP Isotopes' total liabilities were at $43.18 million at the end of 2024, a 395.7% increase from 2023, and a 1,512.0% increase since 2022.

How much cash does ASP Isotopes have?

In the past 2 years, ASP Isotopes' cash and equivalents has ranged from $2.39 million in 2022 to $61.89 million in 2024, and is currently $61.89 million as of their latest financial filing in 2024.

How has ASP Isotopes' book value per share changed over the last 2 years?

Over the last 2 years, ASP Isotopes' book value per share changed from 0.37 in 2022 to 0.67 in 2024, a change of 83.1%.

Related Companies

This page (NASDAQ:ASPI) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Financials

Frequently Asked Questions About ASP Isotopes' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Financials

Annual Income Statements for ASP Isotopes

Quarterly Income Statements for ASP Isotopes

Annual Cash Flow Statements for ASP Isotopes

Quarterly Cash Flow Statements for ASP Isotopes

Annual Balance Sheets for ASP Isotopes

Quarterly Balance Sheets for ASP Isotopes

Annual Metrics and Ratios for ASP Isotopes

Quarterly Metrics and Ratios for ASP Isotopes

Frequently Asked Questions About ASP Isotopes' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools